The core activity of CanVirex AG is the development and research in the field of immunooncology and vaccination, particularly in biotechnology and pharmaceuticals. The company focuses on the development of viral vectors and immunotherapeutics.
AI-generated
Comparisons
CanVirex AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank CanVirex AG by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.